Streptococcal B vaccine conjugate

Drug Profile

Streptococcal B vaccine conjugate

Latest Information Update: 04 Jan 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Channing Laboratory; Harvard Medical School
  • Class Glycoconjugates; Polysaccharides; Streptococcal vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Streptococcal infections

Most Recent Events

  • 06 Dec 2001 A study has been added to the Bacterial Infections immunogenicity section
  • 17 Feb 2000 Investigation in Streptococcal infections in USA (Unknown route)
  • 17 Feb 2000 A clinical study has been added to the adverse events section and the Bacterial Infections immunogenicity section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top